advertisement

---

Wei W 10

Showing records 1 to 10 | Display all abstracts from Wei W

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang H
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Li G; Wang N
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Zhang R
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang Y
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wang Y; Chen R
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Wei W; Lu H
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Liu Y; Li Y
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhai S
Frontiers in pharmacology 2022; 13: 919688

---

100271 Retrospective analysis of secondary enucleation for uveal melanoma after plaque radiotherapy
Wei W
BMC Ophthalmology 2022; 22: 163

---

100824 Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
Zhang C
Frontiers in pharmacology 2022; 13: 919688

---